Q1 2025 Management View CEO Thibaut Mongon highlighted Kenvue’s deliberate plans to accelerate profitable growth in 2025, focusing on leveraging its consumer health brands and navigating macro shifts.

Q3 2025 Management View CEO Joanne Crevoiserat highlighted record third-quarter revenue and earnings per share, with revenue ...

Software firm, Palantir (NASDAQ: PLTR) is up more than 8.5% after reporting solid earnings growth on Monday. The company ...

Explore Lumen Technologies' AI transformation, $8B in orders, and financial shift. High-risk, high-reward stock—ideal for ...

Fiscal 2025 adjusted diluted EPS guidance was raised to $3 to $3.15, reflecting strong first-half performance and continued business momentum. UGI reported $1.9 billion in available liquidity and a ...

Evergy announced that it would be paying shareholders a dividend after it reported a $2.3 million earnings increase. According to Evergy’s Q1 ...

Dabur share price has gained 3% in one month and has declined 10% in three months. In 2025 so far, Dabur shares have fallen 7 ...

Ford Motor Company has announced that it expects a $1.5 billion reduction in EBIT this year as the result of new import ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

The headline numbers for Match Group (MTCH) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Prime Medicine, Inc. (PRME) delivered earnings and revenue surprises of -25% and 68.25%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Operator: Good morning, everyone, and welcome to New York Times [Technical Difficulty] [Operator Instructions] After today’s ...